Advanced Search


Study ID Status Title Patient Level Data
200207 Completed A Double Blind, Placebo Controlled, Single and Repeat Dose Escalation Study of GSK2838232 with and without Ritonavir for 8-11 days in Healthy Subjects
200208 Terminated An open label, experimental medicine investigation of the safety and tolerability of 400 mg b.i.d. GSK2586184 in patients with moderate to severely active ulcerative colitis. Study Listed on
200209 Completed A Prospective Study of Sexual Function in Men Taking Dutasteride for the Treatment of Androgenetic Alopecia
200210 Active not recruiting First Line and Sequential Use of Pazopanib Followed by Mammalian Target of Rapamycin (mTOR) Inhibitor Therapy among Patients with Advanced/Metastatic Renal Cell Carcinoma in a United States Community Oncology Setting
200211 Active not recruiting Persistence and Compliance among United States Patients Receiving Pazopanib or Sunitinib as First‐Line Therapy for Advanced Renal Cell Carcinoma
200215 Active not recruiting The epidemiology, management patterns, and direct costs of treating malignant melanoma: a retrospective and prospective observational survey using the Canadian Melanoma Research Network (CMRN) Patient Registry
200217 Active not recruiting Treatment retention rate of paroxetine CR in the naturalistic setting (A pilot investigation)
200220 Completed A systematic review and network meta-analysis of IPX066 and other common therapies for management of symptoms in patients with advanced Parkinson’s disease (patients experiencing wearing-off on levodopa therapy)
200226 Completed Adjusting for treatment crossover in a Phase 2 trial of dabrafenib and trametinib combination therapy in patients with metastatic melanoma
200227 Active not recruiting HO-13-9058 - Indirect treatment comparison (ITC) of mepolizumab versus omalizumab in the treatment of adults and adolescents (aged >=12 years) with severe asthma
200229 Completed An Open Label, Randomized, Two Part Study to Evaluate the CYP2C8- and OATP1B1-Mediated Drug-Drug Interaction Potential of GSK1278863 with Pioglitazone and Rosuvastatin as Victims and Trimethoprim as Perpetrator in Healthy Adult Volunteers
200239 Completed Longitudinal Analysis of Efficacy and Safety of Alitretinoin in Patients with Severe Chronic Hand Eczema Refractory to Corticosteroids
200249 Recruiting A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and MK 3475 in Subjects with Advanced Renal Cell Carcinoma
200252 Completed A single-centre, randomized, open-label, 3-period crossover study using other inhalers as controls, non-pharmacological intervention, to investigate the operability of novel inhaler in subjects who have not previously used any of the inhalers assessed
200254 Completed An Open Label, Single Sequence, Three Period, Drug-Drug Interaction Study To Examine The Pharmacokinetics Of Dutasteride And Tamsulosin And Their Interactions In Chinese Male Healthy Volunteers Study Listed on
200255 Withdrawn Evaluation of antibody persistence for GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine (GSK-580299) administered in healthy adults and adolescents, 6.5 years after first vaccination in the primary study
200258 Completed A meta-analysis of randomized, controlled trials in metastatic melanoma establishes progression free survival as a surrogate for overall survival
200260 Completed An Open-Label, Randomised, Two Treatment, Four-Way Cross-Over (Replicate Design), Two Sequence, Repeat Dose, Single Centre Study in Healthy Volunteers to Compare the Pharmacokinetics of Fluticasone Propionate/Salmeterol (100/50 mcg) Delivered Via the Low Airflow Resistance ROTAHALER Inhaler Relative to Fluticasone Propionate/Salmeterol (100/50 mcg) Delivered Via the DISKUS Inhaler Study Listed on
200262 Completed A FTIH study with GSK3008348 in healthy volunteers and patients with Idiopathic Pulmonary Fibrosis
200274 Recruiting A cohort study to determine the incidence of dengue fever and to build capacity for dengue vaccine trials in dengue-endemic regions of South Asia
200276 Completed Meta-Analysis of Liver Chemistry Abnormalities with GW786034 (Pazopanib) Treatment in Advanced/Metastatic Renal Cell Carcinoma, Soft Tissue Sarcoma and Ovarian Cancer
200277 Active not recruiting Meta-Analysis Plan for liver analyses with GW786034 (pazopanib) treatment in advanced/metastatic renal cell carcinoma and soft tissue sarcoma to support a regulatory post marketing requirement
200281 Recruiting Drug Use Investigation of VOTRIENT® Tablets (Investigation in Patients with Renal Cell Carcinoma)
200284 Completed A Relative Bioavailability Study to Compare the Pharmacokinetics of a Fixed Dose Combination of Fluticasone Furoate and Levocabastine with Levocabastine and Fluticasone Furoate Alone Study Listed on
200285 Completed A randomized, double-blind, placebo controlled, 3 way cross over study in subjects with allergic rhinitis to assess the effect of intranasal repeat doses of levocabastine when administered once daily or twice daily on the symptoms of rhinitis in an allergen challenge chamber Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.